1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Type
• Market Snapshot, By Drug Class
• Market Snapshot, By Route of Administration
• Market Snapshot, By Application
• Market Snapshot, By Distribution Channel
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Market Trends
• New Product Launches
• Regulatory Scenario   
• PORTER’s Five Forces Analysis
• Business Development Strategies
• Epidemiology
• Disease Awareness Programs
• Treatment Safety and Efficacy Analysis
• Pipeline Analysis

4. Global Digestive Drugs Market, By Type, 2026 – 2033, (US$ Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Branded
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Generic
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)

5. Global Digestive Drugs Market, By Drug Class, 2026 – 2033, (US$ Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• 5-aminosalicylates
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• GI stimulants
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Laxatives
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Antacids
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• H2 Antagonists
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Antidiarrheals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)

6. Global Digestive Drugs Market, By Route of Administration, 2026 – 2033, (US$ Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Oral
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Intravenous
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)

7. Global Digestive Drugs Market, By Application, 2026 – 2033, (US$ Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Gastroesophageal Reflux Disease (GERD)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Irritable Bowel Syndrome
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Ulcerative Colitis
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Others (Chronic diarrhoea, constipation etc.)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)

8. Global Digestive Drugs Market, By Distribution Channel, 2026 – 2033, (US$ Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Hospital Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (US$ Mn)

9. Global Digestive Drugs Market, By Region, 2026 – 2033, (US$ Mn)

• Introduction
• Market Share Analysis, By Region, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, For Regions, 2022–2033
• Regional Trends
• North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Mn)
• U.S.
• Canada
• Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Mn)
• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (US$ Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (US$ Mn)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Market Share Analysis
• GlaxoSmithKline plc
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• AbbVie Inc. (Allergan)
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Takeda Pharmaceutical Company Limited
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Pfizer Inc
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• AstraZeneca plc
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Marksans Pharma
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Tillotts Pharma AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Salix Pharmaceuticals
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Otsuka Pharmaceutical Co., Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Merck & Co., Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Lexicon Pharmaceuticals, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Bayer AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Cadila Healthcare Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

11. Section

• Research Methodology
• About us